Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACONW
Aclarion
$0.03
-4.7%		$0.03
$0.02
▼
$0.23
N/AN/A23,245 shs5,220 shs
HTGMQ
HTG Molecular Diagnostics
$0.00
$0.00
▼
$0.00
N/A3.061,989 shsN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
$0.03
$0.03
$0.02
▼
$0.15
N/AN/A10,422 shsN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$0.00
$0.00
▼
$0.00
$1K1.091,056 shsN/A
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACONW
Aclarion
-4.67%+15.79%+27.68%-17.10%-37.69%
HTGMQ
HTG Molecular Diagnostics
0.00%0.00%0.00%0.00%0.00%
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
0.00%+29.41%+10.74%-17.71%-67.65%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACONW
Aclarion
$0.03
-4.7%		$0.03
$0.02
▼
$0.23
N/AN/A23,245 shs5,220 shs
HTGMQ
HTG Molecular Diagnostics
$0.00
$0.00
▼
$0.00
N/A3.061,989 shsN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
$0.03
$0.03
$0.02
▼
$0.15
N/AN/A10,422 shsN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$0.00
$0.00
▼
$0.00
$1K1.091,056 shsN/A
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACONW
Aclarion
-4.67%+15.79%+27.68%-17.10%-37.69%
HTGMQ
HTG Molecular Diagnostics
0.00%0.00%0.00%0.00%0.00%
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
0.00%+29.41%+10.74%-17.71%-67.65%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aclarion, Inc. stock logo
ACONW
Aclarion
0.00
N/AN/AN/A
HTGMQ
HTG Molecular Diagnostics
0.00
N/AN/AN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
0.00
N/AN/AN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aclarion, Inc. stock logo
ACONW
Aclarion
$83.77KN/AN/AN/AN/AN/A
HTGMQ
HTG Molecular Diagnostics
$6.37M0.00N/AN/AN/ANaN
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
$1.00MN/AN/AN/AN/AN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$9.61M0.00N/AN/A($0.99) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aclarion, Inc. stock logo
ACONW
Aclarion
N/AN/AN/AN/AN/AN/AN/AN/A8/28/2026 (Estimated)
HTGMQ
HTG Molecular Diagnostics
-$21.59M-$2.28N/AN/AN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/AN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
-$17.98M-$5.14N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aclarion, Inc. stock logo
ACONW
Aclarion
N/AN/AN/AN/AN/A
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/AN/AN/AN/AN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aclarion, Inc. stock logo
ACONW
Aclarion
N/A
HTGMQ
HTG Molecular Diagnostics
N/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
5.78%

Insider Ownership

CompanyInsider Ownership
Aclarion, Inc. stock logo
ACONW
Aclarion
N/A
HTGMQ
HTG Molecular Diagnostics
2.60%
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
78.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aclarion, Inc. stock logo
ACONW
Aclarion
7N/AN/ANot Optionable
HTGMQ
HTG Molecular Diagnostics
902.21 million2.16 millionNot Optionable
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
2N/AN/ANot Optionable
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
407.95 million1.75 millionNot Optionable

Recent News About These Companies

ThermoGenesis Holdings Inc.
July 27, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/thmo/financials
CitrusBurn Analyzed (INSIDER REPORT) Does Citrus Burn Natural Weight Loss Supplement Really Work? Achieves 74% Thermogenesis Increase in Clinical Studies
February 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/19/3241422/0/en/citrusburn-analyzed-insider-report-does-citrus-burn-natural-weight-loss-supplement-really-work-achieves-74-thermogenesis-increase-in-clinical-studies.html
THMO | ThermoGenesis Holdings Inc. Annual Cash Flow Statement | MarketWatch
July 29, 2025  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/thmo/financials/cash-flow
The Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat Loss
March 10, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/10/3039487/0/en/the-ice-water-hack-how-aqua-sculpt-boosts-thermogenesis-for-fat-loss.html
Ice Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight Loss
February 20, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/20/3029625/0/en/ice-water-hack-how-aqua-sculpt-improves-thermogenesis-for-weight-loss.html
North American Morning Briefing: Stock Futures, -2-
September 19, 2024  |  morningstar.comM
Is Thermogenesis Holdings Inc Stock (THMO) a Good Investment?
August 8, 2024  |  aaii.comA
ThermoGenesis Holdings (OTC:THMO) Stock Quotes, Forecast and News Summary
July 28, 2024  |  benzinga.comhttps://www.benzinga.com/quote/THMO
ThermoGenesis Holdings (OTC:THMO) Stock, Short Interest Report
July 28, 2024  |  benzinga.comhttps://www.benzinga.com/quote/THMO/short-interest
Why Is ThermoGenesis (THMO) Stock Down 37% Today?
June 12, 2024  |  investorplace.comhttps://investorplace.com/2024/06/why-is-thermogenesis-thmo-stock-down-37-today/
THMO Stock Earnings: ThermoGenesis Holdings Misses EPS, Misses Revenue for Q1 2024
May 17, 2024  |  investorplace.comhttps://investorplace.com/earning-results/2024/05/thmo-stock-earnings-thermogenesis-holdings-for-q1-of-2024/?cc=marketbeat&cp=pdtk
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Is About To Turn The Corner
February 27, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/thermogenesis-holdings-inc-nasdaq-thmo-111508436.html?.tsrc=rss
ThermoGenesis Holdings, Inc.
January 9, 2024  |  thestreet.comhttps://www.thestreet.com/quote/THMO
ThermoGenesis Holdings Stock (NASDAQ:THMO) Dividends: History, Yield and Dates
December 16, 2023  |  benzinga.comhttps://www.benzinga.com/quote/THMO/dividend
Shareholders Will Probably Hold Off On Increasing ThermoGenesis Holdings, Inc.'s (NASDAQ:THMO) CEO Compensation For The Time Being
December 8, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/shareholders-probably-hold-off-increasing-100950163.html?.tsrc=rss
ThermoGenesis Holdings Recent Insider Activity
November 21, 2023  |  benzinga.comhttps://www.benzinga.com/news/23/11/35896638/thermogenesis-holdings-recent-insider-activity
ThermoGenesis Holdings, Inc.: ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
November 15, 2023  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2023-11/60655064-thermogenesis-holdings-inc-thermogenesis-holdings-announces-third-quarter-2023-financial-results-and-provides-corporate-update-008.htm
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call Transcript
November 14, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/thermogenesis-holdings-inc-nasdaq-thmo-152609944.html?.tsrc=rss
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/thermogenesis-holdings-announces-third-quarter-210500777.html?.tsrc=rss
ThermoGenesis Q3 Earnings Preview
November 12, 2023  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/thermogenesis-q3-earnings-preview/ar-AA1jOtWr

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aclarion stock logo

Aclarion NASDAQ:ACONW

$0.03 0.00 (-4.67%)
As of 08/14/2026 01:51 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

HTG Molecular Diagnostics NASDAQ:HTGMQ

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

60 Degrees Pharmaceuticals stock logo

60 Degrees Pharmaceuticals NASDAQ:SXTPW

$0.03 0.00 (0.00%)
As of 08/14/2026

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.

ThermoGenesis stock logo

ThermoGenesis NASDAQ:THMO

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas